Quality of Life analysis using ceramide cream for skin toxicity caused by cetuximab for advanced colorectal cancer (Multicentric study).

Quality of Life analysis using ceramide cream for skin toxicity caused by cetuximab for advanced colorectal cancer (Multicentric study). - Quality of Life analysis using ceramide cream for skin toxicity caused by cetuximab for advanced colorectal cancer (Multicentric study).

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009654

Enrollment

Registered

2012-12-28

Start date

2013-01-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

ceramide cream

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) decreased Qualty of Life by skin toxicity of cetuximab (Skindex16 over 27) 2) ECOG PS 0,1 3) able to use ceramide cream 4) able to answer to questionaire 5) life expectancy over 3months

Exclusion criteria

Exclusion criteria: 1) Other reason causing skin symptom 2) Not apropriate to registration

Design outcomes

Primary

Measure	Time frame
response rate of Quality of Life (Efficacy)	—

Secondary

Measure	Time frame
Adverse events	—

Countries

Japan

Contacts

Public ContactMasato Nakamura

Aizawa Hospital Aizawa Comprehensive Cancer Center

geka-dr7@ai-hosp.or.jp+81-263-33-8600

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026